Provided by Tiger Trade Technology Pte. Ltd.

HORIZON KINETICS MEDICAL ETF

35.07
+0.00460.01%
Volume:957
Turnover:33.53K
Market Cap:16.48M
PE:- -
High:35.07
Open:35.00
Low:35.00
Close:35.06
52wk High:37.90
52wk Low:28.87
Shares:469.95K
Float Shares:469.95K
Volume Ratio:0.43
T/O Rate:0.20%
Dividend:0.41
Dividend Rate:1.17%
ROE:--
ROA:--
PB:--
PE(LYR):- -

Loading ...

Top Midday Decliners

MT Newswires Live
·
Sep 09

Jefferies says definitive readthrough to Sarepta from Novartis news ‘premature’

TIPRANKS
·
Sep 09

Mizuho sees Sarepta selloff on Novartis DM1 miss as overdone

TIPRANKS
·
Sep 09

Amgen's Olpasiran May Still Show Heart-Risk Reduction Despite Novartis Miss, UBS Says

MT Newswires Live
·
Sep 09

Dow Jones Top Company Headlines at 1 PM ET: Amazon Sued for Allegedly Discriminating Against Pregnant Workers | GE ...

Dow Jones
·
Sep 09

H.C. Wainwright reiterates Sell on Sarepta after Novartis study miss

TIPRANKS
·
Sep 09

Top Midday Stories: GE Aerospace to Acquire Consolidated Precision Products; Qualcomm Issues Share Warrant to Amazon

MT Newswires Live
·
Sep 08

Dow Jones Top Company Headlines at 11 am ET: GE Aerospace to Buy Consolidated Precision Products | GameStop ...

Dow Jones
·
Sep 08

Novartis falls -12.9%

TIPRANKS
·
Sep 08

U.S. Stocks on the MOVE-Sigma Lithium, Shake Shack, Novartis

Reuters
·
Sep 08

Novartis's Failed Trial for Cholesterol Drug Leads to Broad Biopharma Selloff

Dow Jones
·
Sep 08

Novartis AG Stock (NVS) Opened Down by 12.63% on Sep 8: What Investors Need To Know

TradingKey
·
Sep 08

Dow Drops 438 Points on Losses for Amgen, Salesforce Shares

Dow Jones
·
Sep 08

Novartis Down over 12%, on Pace for Record Percent Decrease

Dow Jones
·
Sep 08

Sector Update: Healthcare

MT Newswires Live
·
Sep 08

Novartis is Having a Very Bad September-and More Pain Could be on the Way

Dow Jones
·
Sep 08

Update: US Equity Futures Mostly Lower as Traders Assess Rising Oil, Canadian Retaliatory Tariffs

MT Newswires Live
·
Sep 08

Chengdu Easton Biopharmaceuticals Schedules Participation in Semi-Annual Innovation Drug Sector Earnings Call

Deep News
·
Sep 08

Structure Therapeutics reports ACCG-2671, aleniglipron trial results

TIPRANKS
·
Sep 08

The AI Drug Discovery Sector Enters Its Value-Realization Phase, Unlocking Fresh Growth Avenues for Innovative Medicines

Deep News
·
Sep 08